Filtern
Volltext vorhanden
- ja (2)
Gehört zur Bibliographie
- ja (2)
Erscheinungsjahr
- 2020 (2) (entfernen)
Dokumenttyp
Sprache
- Englisch (2)
Schlagworte
- resveratrol (2) (entfernen)
Institut
EU-Projektnummer / Contract (GA) number
- 309962 (1)
The initial goal was the conversion of Bifidobacterium adolescentis Sucrose Phosphorylase (BaSP) into a polyphenol glucosidase by structure based enzyme engineering. BaSP was chosen because of its ability to utilize sucrose, an economically viable and sustainable donor substrate, and transfer the glucosyl moiety to various acceptor substrates. The introduction of aromatic residues into the active site was considered a viable way to render it more suitable for aromatic acceptor compounds by reducing its polarity and potentially introducing π-π-interactions with the polyphenols. An investigation of the active site revealed Gln345 as a suitable mutagenesis target. As a proof of concept BaSP Q345F was employed in the glycosylation of (+)-catechin, (-)-epicatechin and resveratrol. The variant was selective for the aromatic acceptor substrates and the glucose disaccharide side reaction was only observed after almost quantitative conversion of the aromatic substrates. A crystal structure of BaSP Q345F in complex with glucose was obtained and it displayed an unexpected shift of an entire domain by 3.3 Å. A crystal structure of BaSP D192N-Q345F, an inactive variant in complex with resveratrol-3-α-D-glucosid, the glucosylation product of resveratrol, synthesized by BaSP Q345F was solved. It proved that the domain shift is in fact responsible for the ability of the variant to glycosylate aromatic compounds. Simultaneously a ligand free crystal structure of BaSP Q345F disproved an induced fit effect as the cause of the domain shift. The missing link, a crystal structure of BaSP Q345F in the F-conformation is obtained. This does not feature the domain shift, but is in outstanding agreement with the wildtype structure. The domain shift is therefore not static but rather a step in a dynamic process. It is further conceivable that the domain shifted conformation of BaSP Q345F resembles the open conformation of the wild type and that an adjustment of a conformational equilibrium as a result of the Q345F point mutation is observed. An investigation into the background reaction, the formation of glucose-glucose disaccharides of BaSP Q345F and three further variants that addressed the same region (L341C, D316C-L341C and D316C-N340C) revealed the formation of nigerose by BaSP Q345F.
When aiming at cell‐based therapies in osteoarthritis (OA), proinflammatory conditions mediated by cytokines such as IL‐1β need to be considered. In recent studies, the phytoalexin resveratrol (RSV) has exhibited potent anti‐inflammatory properties. However, long‐term effects on 3D cartilaginous constructs under inflammatory conditions with regard to tissue quality, especially extracellular matrix (ECM) composition, have remained unexplored. Therefore, we employed long‐term model cultures for cell‐based therapies in an in vitro OA environment and evaluated effects of RSV. Pellet constructs made from expanded porcine articular chondrocytes were cultured with either IL‐1β (1–10 ng/ml) or RSV (50 μM) alone, or a cotreatment with both agents. Treatments were applied for 14 days, either directly after pellet formation or after a preculture period of 7 days. Culture with IL‐1β (10 ng/ml) decreased pellet size and DNA amount and severely compromised glycosaminoglycan (GAG) and collagen content. Cotreatment with RSV distinctly counteracted the proinflammatory catabolism and led to partial rescue of the ECM composition in both culture systems, with especially strong effects on GAG. Marked MMP13 expression was detected in IL‐1β‐treated pellets, but none upon RSV cotreatment. Expression of collagen type I was increased upon IL‐1β treatment and still observed when adding RSV, whereas collagen type X, indicating hypertrophy, was detected exclusively in pellets treated with RSV alone. In conclusion, RSV can counteract IL‐1β‐mediated degradation and distinctly improve cartilaginous ECM deposition in 3D long‐term inflammatory cultures. Nevertheless, potential hypertrophic effects should be taken into account when considering RSV as cotreatment for articular cartilage repair techniques.